Aptima SARS-CoV-2 Assay
HSA Provisional Authorisation
*Professional Use Only
The Aptima™ SARS-CoV-2 assay is a nucleic acid amplification in-vitro diagnostic test intended for the qualitative detection of RNA from SARS-CoV-2 isolated and purified from nasopharyngeal (NP), nasal, mid-turbinate, and oropharyngeal (OP) swab specimens, nasopharyngeal wash/ aspirate or nasal aspirates obtained from individuals meeting COVID-19 clinical and/or epidemiological criteria.
Authorized for use in both symptomatic and asymptomatic people.
Power of sensitivity: Most analytically sensitive, fully-automated, high-throughput
Flexible: A single patient specimen can be tested for SARS-CoV-2 as well as other
common respiratory viruses with symptoms that overlap with COVID-19 boosting efficiency and increasing clinical insight.
For use with nasopharyngeal (NP), nasal, mid-turbinate, and oropharyngeal (OP) swab specimens, nasopharyngeal wash/aspirate, or nasal wash.
✓ Viral transport medium (VTM/UTM)
✓ Liquid Amies
✓ Specimen transport medium (STM)
✓ Aptima® Multitest Swab Specimen Collection Kit
Click Here for more product information on our partner site
Reference MaterialsAccuPlex™ SARS-CoV-2 Reference Material Kit (v1) SeraCare | 0505-0126 - AccuPlex™ SARS-CoV-2 Reference Material Kit (Full Genome) SeraCare | 0505-0159 - AccuPlex™ SARS-CoV-2, Flu A/B, and RSV Reference Material Kit SeraCare | 0505-0174 - AccuPlex™ SARS-CoV-2 in Synthetic Oral Fluid SeraCare | 0505-0222 - ACCURUN SARS-CoV-2 Antigen Reference Material Kit SeraCare | 2015-0231
Verification PanelAccuPlex™ SARS-CoV-2 Verification Panel (Full Genome) SeraCare | 0505-0168 - AccuPlex™ SARS-CoV-2, Flu A/B, and RSV Verification Panel SeraCare | 0505-0183
VariantAccuPlex™ SARS-CoV-2 Variant Panel 1 SeraCare | 0505-0241
External Quality AssuranceSARS-CoV-2 Liquid (Molecular) American Proficiency Institute | 385 - SARS-CoV-2 Antigen American Proficiency Institute | 387